1Pfeffer MA. ACE inhibition in acute myocardial infarction [J]. N Engl J Med, 1995,332:118-120.
2Flather MD, Yusuf S, Kober L, et al. Longterm ACE-inhibitor therapy in patients with heart failure or left-ventricular dysfunction: a systematic overview of data from individual patients [J]. Lancet, 2000,355:1575-1581.
3Hunt SA, Baker DW, Chin MH, et al. ACC/AHA guidelines for the evaluation and management of chronic heart failure in the adult: executive summary: a report of the American College of Cardiology/American Heart Association Task Force on Practice Guidelines (Committee to revise the 1995 Guidelines for the Evaluation and Management of Heart Failure) [J]. J Am Coll Cardiol, 2001,38:2101-2113.
4Remme WJ, Swedberg K. Guidelines for the diagnosis and treatment of chronic heart failure [J]. Eur Heart J, 2001,22: 1527-1560.
5Dickstein K, Kjekshus J, OPTIMAAL Steering Committee of the OPTIMAAL Study Group. Effects of losartan and captopril on mortality and morbidity in high-risk patients after acute myocardial infarction: the OPTIMAAL randomised trial [J]. Lancet, 2002,360:752-760.
6Dickstein K. What did we learn from the OPTIMAAL trial? What can we expect from VALIANT? [J]. Am Heart J, 2003, 145: 754-757.
7Pfeffer MA, Braunwald E, Moyé LA, et al. Effect of captopril on mortality and morbidity in patients with left ventricular dysfunction after myocardial infarction. Results of the survival and ventricular enlargement trial [J]. N Engl J Med, 1992, 327: 669-677.
8Kober L, Torp-Pedersen C, Carlsen JE, et al. A clinical trial of the angiotensin-converting-enzyme inhibitor trandolapril in patients with left ventricular dysfunction after myocardial infarction [J]. N Engl J Med, 1995,333:1670-1676.
9The Acute Infarction Ramipril Efficacy (AIRE) Study Investigators. Effect of ramipril on mortality and morbidity of survivors of acute myocardial infarction with clinical evidence of heart failure [J ]. Lancet, 1993,342: 821-828.
10Pfeffer MA, McMurray J, Leizoroviez A, et al. Valsartan in acute myocardial infarction trial (VALIANT): rationale and design [J]. Am Heart J, 2000,140:626-633.